Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260242 (US9522914, A-44) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.160 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260242 (US9522914, A-44) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.160 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260267 (US9522914, B-20) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.430 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260267 (US9522914, B-20) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.430 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260241 (US9522914, A-43) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.490 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260241 (US9522914, A-43) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.490 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260347 (US9522914, D-36) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.610 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260347 (US9522914, D-36) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.610 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260206 (US9522914, A-08) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.820 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260206 (US9522914, A-08) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.820 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260237 (US9522914, A-39) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1a/V1b receptor (Homo sapiens (Human)) | BDBM50137948 (Biphenyl-2-carboxylic acid [2-[3-(4-methyl-[1,4]di...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | <1 | n/a | n/a | n/a | n/a | n/a | n/a |
Central Pharmaceutical Research Institute Curated by ChEMBL | Assay Description Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human platelet | J Med Chem 47: 101-9 (2003) Article DOI: 10.1021/jm030287l BindingDB Entry DOI: 10.7270/Q2TX3DT7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM50345056 (2-(6-(3-((dimethylamino)methyl)phenyl)-2-(4-fluoro...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
MSD Curated by ChEMBL | Assay Description Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells co-expressing VIP-luciferase by scintillation counting-based whole... | Bioorg Med Chem Lett 21: 3813-7 (2011) Article DOI: 10.1016/j.bmcl.2011.04.022 BindingDB Entry DOI: 10.7270/Q2CV4J34 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260237 (US9522914, A-39) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260264 (US9522914, B-17) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260248 (US9522914, B-01) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260264 (US9522914, B-17) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260248 (US9522914, B-01) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260329 (US9522914, D-18) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260329 (US9522914, D-18) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM50345045 (CHEMBL1778950 | N-isopropyl-2-(2-(3-methoxyphenyl)...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
MSD Curated by ChEMBL | Assay Description Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells co-expressing VIP-luciferase by scintillation counting-based whole... | Bioorg Med Chem Lett 21: 3813-7 (2011) Article DOI: 10.1016/j.bmcl.2011.04.022 BindingDB Entry DOI: 10.7270/Q2CV4J34 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260308 (US9522914, C-19) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260249 (US9522914, B-02) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260308 (US9522914, C-19) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260256 (US9522914, B-09) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260256 (US9522914, B-09) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260249 (US9522914, B-02) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260213 (US9522914, A-15) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260213 (US9522914, A-15) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260316 (US9522914, D-05) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260316 (US9522914, D-05) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM50416630 (CHEMBL1223545) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 2.51 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline Curated by ChEMBL | Assay Description Antagonist activity at human vasopressin 1b receptor expressed in CHO cells assessed as inhibition of vasopressin-induced intracellular calcium mobil... | Bioorg Med Chem Lett 20: 5044-9 (2010) Article DOI: 10.1016/j.bmcl.2010.07.037 BindingDB Entry DOI: 10.7270/Q24J0GC3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260220 (US9522914, A-22) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260220 (US9522914, A-22) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260352 (US9522914, D-41) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260352 (US9522914, D-41) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260341 (US9522914, D-30) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260255 (US9522914, B-08) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260341 (US9522914, D-30) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260255 (US9522914, B-08) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260342 (US9522914, D-31) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260342 (US9522914, D-31) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM50338810 (CHEMBL1684573 | N-isopropyl-2-(2-(3-methoxyphenyl)...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
MSD Curated by ChEMBL | Assay Description Displacement of [3H]AVP from human V1b receptor expressed in CHO cells co-expressing VIP-luciferase by whole cell binding assay | Bioorg Med Chem Lett 21: 1871-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.081 BindingDB Entry DOI: 10.7270/Q2BR8SG4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM50338810 (CHEMBL1684573 | N-isopropyl-2-(2-(3-methoxyphenyl)...) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
MSD Curated by ChEMBL | Assay Description Displacement of [3H]AVP from human vasopressin V1b receptor expressed in CHO cells by whole cell binding assay | Bioorg Med Chem Lett 21: 1871-5 (2011) Article DOI: 10.1016/j.bmcl.2010.12.081 BindingDB Entry DOI: 10.7270/Q2BR8SG4 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1a/V1b receptor (Homo sapiens (Human)) | BDBM50137940 (Biphenyl-2-carboxylic acid [2-[4-(4-dimethylamino-...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Central Pharmaceutical Research Institute Curated by ChEMBL | Assay Description Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human platelet | J Med Chem 47: 101-9 (2003) Article DOI: 10.1021/jm030287l BindingDB Entry DOI: 10.7270/Q2TX3DT7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260219 (US9522914, A-21) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260219 (US9522914, A-21) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260345 (US9522914, D-34) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260253 (US9522914, B-06) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | 7.4 | 25 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2KS6PR7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vasopressin V1b receptor (Homo sapiens (Human)) | BDBM260253 (US9522914, B-06) | UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | 7.4 | 4 |
TAISHO PHARMACEUTICAL CO., LTD US Patent | Assay Description Human V1b receptor was transiently expressed in 293FT cells (Invitrogen). The cells were collected and then homogenated in a 15 mmol/L tris-hydrochlo... | US Patent US9522914 (2016) BindingDB Entry DOI: 10.7270/Q2WM1CB9 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 622 total ) | Next | Last >> |